TABLE 2.

Comorbid Conditions Among Screened Participants in the Weqaya Study Cohort: Abu Dhabi, United Arab Emirates, 2009–2010

	Obesity, No. (%)	Overweight, No. (%)	Central Obesity, No. (%)	Dyslipidemia, No. (%)	Hypertension, No. (%)	Smoking, No. (%)	Prediabetes, No. (%)	Diabetes, No. (%)
Obesity			12 115 (69.0)	9123 (53.5)	5666 (33.1)	1 822 (10.42)	5313 (31.7)	4523 (27.0)
Overweight			8995 (56.9)	7318 (47.3)	3320 (21.4)	1978 (12.6)	4258 (27.8)	2565 (16.7)
Central obesity	12 115 (44.9)	8995 (33.4)		14 355 (53.8)	8464 (32.7)	3268 (12.0)	7512 (28.5)	6983 (26.5)
Dyslipidemia	9123 (42.8)	7318 (34.3)	14 355 (66.3)		6836 (32.6)	3478 (16.1)	5689 (27.6)	5851 (28.4)
Hypertension	5666 (51.5)	3320 (30.2)	8464 (74.4)	6836 (63.3)		1183 (10.5)	2608 (24.8)	4665 (44.4)
Smoking	1822 (10.4)	1978 (34.4)	3268 (56.4)	3478 (60.9)	1183 (20.7)		1622 (28.7)	708 (12.5)
Prediabetes	5313 (40.8)	4258 (32.7)	7512 (57.2)	5689 (43.6)	2608 (19.9)	1622 (12.4)
Diabetes	4523 (54.3)	2565 (30.8)	6983 (81.9)	5851 (72.8)	4665 (58.9)	708 (8.3)